Is AxoGen, Inc. overvalued?

AxoGen, Inc. (AXGN) — key valuation metrics and fundamentals.

No verdict

Price

$43.36

Fair value

—

Current P/E

—

Normal P/E

27.1

Market cap

$2.33B

Dividend yield

0.0%

Return on equity

-17.9%

Sector

Healthcare

Fair value compares AXGN's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks